ATE218535T1 - Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung - Google Patents

Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung

Info

Publication number
ATE218535T1
ATE218535T1 AT97905261T AT97905261T ATE218535T1 AT E218535 T1 ATE218535 T1 AT E218535T1 AT 97905261 T AT97905261 T AT 97905261T AT 97905261 T AT97905261 T AT 97905261T AT E218535 T1 ATE218535 T1 AT E218535T1
Authority
AT
Austria
Prior art keywords
hydrogen
compositions
aminotetralin derivatives
alkoxy
halogen
Prior art date
Application number
AT97905261T
Other languages
English (en)
Inventor
Edward John Warawa
Bernard Migler
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Application granted granted Critical
Publication of ATE218535T1 publication Critical patent/ATE218535T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/74—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with rings other than six-membered aromatic rings being part of the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Psychology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT97905261T 1996-03-01 1997-02-25 Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung ATE218535T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1264096P 1996-03-01 1996-03-01
PCT/GB1997/000516 WO1997031887A1 (en) 1996-03-01 1997-02-25 Aminotetralin derivatives and compositions and method of use thereof

Publications (1)

Publication Number Publication Date
ATE218535T1 true ATE218535T1 (de) 2002-06-15

Family

ID=21755962

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97905261T ATE218535T1 (de) 1996-03-01 1997-02-25 Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung

Country Status (14)

Country Link
US (1) US5807897A (de)
EP (1) EP0883599B1 (de)
JP (1) JP4083221B2 (de)
KR (1) KR19990087369A (de)
CN (1) CN1212682A (de)
AT (1) ATE218535T1 (de)
AU (1) AU733264B2 (de)
DE (1) DE69713067T2 (de)
IL (1) IL125907A0 (de)
NO (1) NO983990D0 (de)
NZ (1) NZ330974A (de)
TW (1) TW409113B (de)
WO (1) WO1997031887A1 (de)
ZA (1) ZA971670B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726736D0 (en) 1997-12-18 1998-02-18 Zeneca Ltd Chemical compounds
JP2002533447A (ja) * 1998-12-24 2002-10-08 アストラゼネカ・アクチエボラーグ 神経疾患の治療に有用な１，４−ジアザシクロヘプタン誘導体
GB9914015D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
GB9914025D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
GB9914024D0 (en) * 1999-06-17 1999-08-18 Zeneca Ltd Chemical compounds
CA2536073A1 (en) * 2003-08-18 2005-02-24 H. Lundbeck A/S Trans-1(6-chloro-3-phenylindan-1-yl)-3,3-dimethylpiperazine
TWI453198B (zh) * 2005-02-16 2014-09-21 Lundbeck & Co As H 製造反式-1-((1r,3s)-6-氯基-3-苯基茚滿-1-基) -3 , 3 -二甲基六氫吡與其鹽類之方法及製造4-((1r , 3s）-6 -氯基-3-苯基茚滿-1-基 )-1,2,2-三甲基六氫吡與其鹽類之方法
TWI376373B (en) * 2005-02-16 2012-11-11 Lundbeck & Co As H Crystalline base of a pharmaceutical compound
MX2010012037A (es) * 2008-05-07 2010-11-30 Lundbeck & Co As H Composiciones y uso utiles para tratar trastornos cognitivos.
JP2012504560A (ja) * 2008-10-03 2012-02-23 ハー・ルンドベック・アクチエゼルスカベット 経口製剤
JP2024520832A (ja) 2021-06-08 2024-05-24 エンセオジェニックス バイオサイエンシズ， インコーポレイテッド セロトニン受容体のジメトキシフェニルアルキルアミン活性化剤
CA3242479A1 (en) 2021-12-27 2023-07-06 Atai Therapeutics, Inc. AMINOTERALINE SEROTONIN RECEPTOR ACTIVATORS
US12343319B2 (en) 2023-05-01 2025-07-01 Atai Therapeutics, Inc. Compositions and methods for treatment of diseases and disorders

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4320148A (en) * 1980-11-24 1982-03-16 Smithkline Corporation 2-Aminotetralin compounds, pharmaceutical compositions and method of producing central alpha1 agonist activity
US5225596A (en) * 1989-01-09 1993-07-06 The Upjohn Company Halo substituted aminotetralins
SE8904127D0 (sv) * 1989-12-07 1989-12-07 Astra Ab New biocyclic amino-substituted compounds
EP0450238A1 (de) * 1990-03-30 1991-10-09 Merrell Dow Pharmaceuticals Inc. Verbindungen für die Behandlung von Migräne

Also Published As

Publication number Publication date
NO983990L (no) 1998-08-31
WO1997031887A1 (en) 1997-09-04
ZA971670B (en) 1997-09-01
AU1887997A (en) 1997-09-16
NZ330974A (en) 2000-05-26
US5807897A (en) 1998-09-15
EP0883599A1 (de) 1998-12-16
TW409113B (en) 2000-10-21
JP2000506137A (ja) 2000-05-23
CN1212682A (zh) 1999-03-31
AU733264B2 (en) 2001-05-10
KR19990087369A (ko) 1999-12-27
EP0883599B1 (de) 2002-06-05
JP4083221B2 (ja) 2008-04-30
DE69713067D1 (de) 2002-07-11
DE69713067T2 (de) 2002-12-19
NO983990D0 (no) 1998-08-31
IL125907A0 (en) 1999-04-11

Similar Documents

Publication Publication Date Title
CA2432085A1 (en) Indole derivatives and their use as 5-ht2b and 5-ht2c receptor ligands
LU91751I2 (fr) Asenapin et ses dérivés pharmaceutiquement acceptables (SYCREST®)
MY132705A (en) Novel compounds with analgesic effect
ES2160949T3 (es) Derivados de fenilen-sulfonamida sustituidos en meta.
CA2387517A1 (en) Novel biaryl ether derivatives useful as monoamine reuptake inhibitors
UA66825C2 (uk) Азаполіциклічні сполуки, конденсовані з арилом, фармацевтична композиція, спосіб лікування та спосіб зниження нікотинової залежності
AP9701019A0 (en) Phenylamino-substituted tricycle derivatives.
CA2216796A1 (en) Quinazoline derivatives
MY115662A (en) Novel compounds with analgesic effect
EA200200106A1 (ru) Фармацевтическая композиция леводопа/карбидопа/энтакапон
IL142768A0 (en) N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
DK0668863T3 (da) Quinuclidinderivat som substans P-antagonist
PT1147110E (pt) Derivados de pirazino (aza)-indol
NZ247201A (en) Substituted sulphonylamido- or sulphonamidocarbonyl-pyridine-2-carboxamide derivatives and pharmaceutical compositions
DE69713067D1 (de) Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung
AP9801378A0 (en) 9-amino-3- keto erythromycin derivatives.
BG103947A (en) Derivatives of 9-oxymerythromycin
AU2672995A (en) {a}-annelated pyrrole derivatives and pharmaceutical uses thereof
DK0583485T3 (da) Ethanolaminderivater med sympathomimetiske og anti-pollakisuria-virkninger
DK0572635T3 (da) Hidtil ukendte forbindelser med guanidinstruktur og farmaceutisk komposition indeholdende forbindelserne
GB9418912D0 (en) Pharmaceutically active compounds
DE69631542D1 (de) Neue geranylgeranylderivate, verfahren zu deren herstellung und entsprechende pharmazeutische zusammensetzungen
DE69227583D1 (de) Arylmorpholine, herstellung und verwendung
CA2282279A1 (en) Atropisomers of 3-heteroaryl-4(3h)-quinazolinones for the treatment of neurodegenerative and cns-trauma related conditions
RU94046144A (ru) Замещенные (арилалкиламинобензил) аминопропионамидные производные, их применение, способы их получения, фармкомпозиция

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties